Steven Cohen Point72 Asset Management
Steven Cohen is the founder of Point72 Asset Management and previously built SAC Capital into one of the industry’s most profitable trading firms. Point72 operates a multi-manager platform combining fundamental long/short equity with systematic and other strategies. Cohen is also a major figure in sports ownership and philanthropy, while remaining one of the most closely followed names in hedge fund trading culture.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$284M |
| 2 |
FISV
Fiserv Inc
FISV
|
+$232M |
| 3 |
Alibaba
BABA
|
+$183M |
| 4 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$123M |
| 5 |
Oracle
ORCL
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$287M |
| 2 |
JD.com
JD
|
+$168M |
| 3 |
Take-Two Interactive
TTWO
|
+$117M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$116M |
| 5 |
Applied Materials
AMAT
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.9% |
| 2 | Technology | 20.77% |
| 3 | Consumer Discretionary | 14.79% |
| 4 | Financials | 9.69% |
| 5 | Industrials | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CALT
326
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
| $10.4M | 0.07% |
+450,000
| New | +$8.91M |
|
327
Arcturus Therapeutics
ARCT
$382M
| $10.4M | 0.07% |
+223,013
| New | +$7.69M |
|
328
Warner Bros
WBD
$71.6B
| $10.4M | 0.07% |
+493,603
| New | +$10.7M |
|
329
Ionis Pharmaceuticals
IONS
$9.93B
| $10.3M | 0.07% |
174,625
+169,052
| +3,033% | +$9.4M |
|
330
CALL
Expedia Group
EXPE
$38.6B
| $10.3M | 0.07% |
125,000
| – | – |
|
331
Acadia Healthcare
ACHC
$2.59B
| $10.2M | 0.07% |
+406,909
| New | +$10.2M |
|
332
Dave & Buster's
PLAY
$357M
| $10.1M | 0.07% |
+760,331
| New | +$10.1M |
|
|
BERY
333
DELISTED
Berry Global Group, Inc.
BERY
| $10.1M | 0.07% |
+248,795
| New | +$9.34M |
|
|
AVLR
334
DELISTED
Avalara, Inc.
AVLR
| $10.1M | 0.07% |
+75,777
| New | +$7.45M |
|
335
Boyd Gaming
BYD
$5.87B
| $10M | 0.07% |
480,559
-610,175
| -56% | -$11.1M |
|
336
Intercontinental Exchange
ICE
$90.5B
| $10M | 0.07% |
109,248
-520,283
| -83% | -$47.6M |
|
337
Lamb Weston
LW
$7.38B
| $9.98M | 0.07% |
156,116
-176,463
| -53% | -$10.7M |
|
338
Parker-Hannifin
PH
$126B
| $9.98M | 0.07% |
54,440
-93,960
| -63% | -$15.2M |
|
339
Akebia Therapeutics
AKBA
$251M
| $9.97M | 0.07% |
734,028
-1,240,292
| -63% | -$12.8M |
|
340
Viatris
VTRS
$18.7B
| $9.96M | 0.07% |
619,572
+431,772
| +230% | +$7M |
|
341
Synchrony
SYF
$25.9B
| $9.93M | 0.06% |
448,264
-2,227,861
| -83% | -$43.4M |
|
|
NUAN
342
DELISTED
Nuance Communications, Inc.
NUAN
| $9.88M | 0.06% |
390,459
+184,982
| +90% | +$3.86M |
|
343
TripAdvisor
TRIP
$1.17B
| $9.86M | 0.06% |
518,631
+103,790
| +25% | +$1.98M |
|
344
CALL
Pfizer
PFE
$160B
| $9.81M | 0.06% |
+316,200
| New | +$10.7M |
|
345
CME Group
CME
$98.9B
| $9.76M | 0.06% |
60,032
| – | – |
|
346
PagerDuty
PD
$950M
| $9.71M | 0.06% |
+339,448
| New | +$8.19M |
|
347
Alaska Air
ALK
$4.51B
| $9.7M | 0.06% |
267,565
-389,926
| -59% | -$12.7M |
|
348
Acadia Pharmaceuticals
ACAD
$5.08B
| $9.62M | 0.06% |
+198,510
| New | +$9.53M |
|
349
Eversource Energy
ES
$26.4B
| $9.6M | 0.06% |
+115,291
| New | +$9.55M |
|
350
argenx
ARGX
$65B
| $9.59M | 0.06% |
+42,574
| New | +$7.56M |
|
Similar funds
Steven Cohen's Q2 2020 Portfolio in Review
As of Q2 2020, Steven Cohen held 1,113 positions worth $15.3B, up 25% from $12.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Steven Cohen's Q2 2020 filing shows 368 new, 189 increased, 211 reduced and 335 closed positions. Its largest new stake was Merck: 3,769,218 shares worth $278M. The largest sale was Micron Technology, an estimated $287M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
- Steven Cohen's largest Q2 2020 buy was Merck: 3,769,218 shares worth $278M.
- Steven Cohen added most to Fiserv Inc in Q2 2020, an estimated $232M increase.
- Steven Cohen's biggest Q2 2020 reduction was Micron Technology, cutting an estimated $287M.
- Steven Cohen fully exited CSX Corp in Q2 2020, selling an estimated $110M.
- Steven Cohen's ten largest holdings make up 16% of its $15.3B portfolio in Q2 2020.
- Steven Cohen opened 368 new positions and closed 335 in Q2 2020.
- Steven Cohen's portfolio value rose 25% quarter-over-quarter to $15.3B.
Based on Point72 Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.